Indo US Bio-Tech Ltd.
BSE: 541304 | Sector: Others |
NSE: N.A. | ISIN Code: INE250Z01010 |
BSE 00:00 | 12 Aug | 84.00 |
0 (0.00%) |
OPEN
84.00 |
HIGH
84.00 |
LOW
84.00 |
NSE 05:30 | 01 Jan | Indo US Bio-Tech Ltd |
OPEN | 84.00 |
PREVIOUS CLOSE | 84.00 |
VOLUME | 1500 |
52-Week high | 104.80 |
52-Week low | 44.62 |
P/E | 14.71 |
Mkt Cap.(Rs cr) | 77 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Indo US Bio-Tech Ltd. (INDOUSBIOTECH) - Financial Overview
Particulars (![]() |
2022 | 2021 | 2020 |
Net Sales | 50.05 | 40.09 | 39.76 |
Operating Profit | 7.13 | 5.57 | 3.97 |
Other Income | 0.18 | 0.04 | 0.01 |
Interest | 1.20 | 1.18 | 0.88 |
Depreciation | 0.44 | 0.26 | 0.23 |
Profit Before Tax | 5.49 | 4.13 | 2.86 |
Tax | 0.25 | -0.97 | 0.33 |
Profit After Tax | 5.24 | 5.10 | 2.53 |
Share Capital | 9.17 | 6.07 | 6.07 |
Reserves | 29.71 | 15.47 | 10.37 |
Net Worth | 38.88 | 21.54 | 16.44 |
Loans | 13.60 | 12.29 | 9.24 |
Gross Block | 5.54 | 2.33 | 2.82 |
Investments | 0.01 | 0.01 | 0.00 |
Cash | 0.05 | 0.13 | 0.20 |
Debtors | 20.54 | 24.69 | 20.98 |
Net Working Capital | 44.60 | 29.50 | 23.00 |
Operating Profit Margin (%) | 14.25 | 13.89 | 9.98 |
Net Profit Margin (%) | 10.47 | 12.72 | 6.36 |
Earning Per Share (Rs) | 5.71 | 8.40 | 4.18 |
Dividend (%) | 0.00 | 0.00 | 0.00 |
Dividend Payout | 0.15 | 0.00 | 0.00 |
Quick Links for Indo US Bio-Tech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices